Table 1A.

Patients characteristics

Characteristics	Decitabine (n=20)	Conventional Care (n=25)	p-value
Age, median [range], years	62, [24–79]	53 [31–72]	0.10
≤ 60	9 (45)	18 (72)	0.12
> 60	11 (55)	7 (28)
CR1	14 (70) [1CRp]	21 (83) [1CRp]	0.26
CR2	6 (30) [1CRp]	3 (12)
CR3	0	1 (4)
Induction regimen			0.20
SDAC + Anthracycline (3+7)	7 (35)	3 (12)
HiDAC + Anthracycline	11 (55)	18 (72)
Single agent (e.g. Clofarabine)	2 (10)	4 (16)
No. of consolidation cycles			0.19
≤ 1	8 (40)	5 (20)
> 1	12 (60)	20 (80)
Cytogenetics			0.99
Intermediate	15 (75)	19 (76)
Unfavorable	5 (25)	5 (20)
Favorable (relapsed)	0	1 (4)